Filter posts

The Guardian: Global defence system to fight virus threats urgently needed

Fresh on the heels of the recent Ebola epidemic, the current Zika virus threat has …

The Hill: Will Support for Biomedical Research Be Dead on Arrival?

In an op-ed over at The Hill, Dr. Claire Pomeroy, an infectious disease specialist and …

Bavarian Nordic CEO Paul Chaplin in San Jose Mercury News: Why an Ebola Vaccine Still Matters

The San Jose Mercury News this weekend published an op-ed by Paul Chaplin, the CEO …

Nature Biotechnology: Outpaced by an outbreak

The current issue of Nature Biotechnology contains an editorial on the response to the Ebola …

The Future of Biodefense: Will Public-Private Partnerships Continue?

Ten years ago, in the wake of the 2001 anthrax attacks, the U.S. government set …